A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

Conditions: Myasthenia Gravis Interventions: Biological: Efgartigimod Sponsors: argenx Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials